Chronic obstructive pulmonary disease.
暂无分享,去创建一个
[1] A. Sandford,et al. Genetic risk factors of chronic obstructive pulmonary disease. , 1997, Swiss medical weekly.
[2] J. Hogg,et al. Chronic obstructive pulmonary disease: an overview of pathology and pathogenesis. , 2008, Novartis Foundation symposium.
[3] J. Zalewska-kaszubska,et al. Anti-inflammatory capabilities of macrolides. , 2001, Pharmacological research.
[4] J. Bartlett,et al. A fresh look at the definition of susceptibility of Streptococcus pneumoniae to beta-lactam antibiotics. , 2001, Archives of internal medicine.
[5] I. Boldur,et al. Chlamydia pneumoniae Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Analysis of 250 Hospitalizations , 2001, European Journal of Clinical Microbiology and Infectious Diseases.
[6] A. Hoberman,et al. Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media , 2001, The Pediatric infectious disease journal.
[7] D. O’Donnell,et al. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[8] M. Leinonen,et al. Infectious etiologies in acute exacerbation of COPD. , 2001, Diagnostic microbiology and infectious disease.
[9] Marilyn Roberts,et al. Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance , 2001, Microbiology and Molecular Biology Reviews.
[10] G. Doern,et al. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] V. Snow,et al. Evidence Base for Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease , 2001, Annals of Internal Medicine.
[12] D. Mccrory,et al. Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Summary and Appraisal of Published Evidence , 2001, Annals of Internal Medicine.
[13] T. Murphy,et al. Bacterial Infection in Chronic Obstructive Pulmonary Disease in 2000: a State-of-the-Art Review , 2001, Clinical Microbiology Reviews.
[14] S. Sethi,et al. Acute Exacerbations of Chronic Bronchitis , 2001, Drugs & aging.
[15] R. Grossman,et al. The Chronic Obstructive Pulmonary Disease Exacerbation , 2000, Clinics in Chest Medicine.
[16] R. Bonomo. Multiple antibiotic-resistant bacteria in long-term-care facilities: An emerging problem in the practice of infectious diseases. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] B. Grant,et al. Airway inflammation and etiology of acute exacerbations of chronic bronchitis. , 2000, Chest.
[18] R. Stockley,et al. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. , 2000, The American journal of medicine.
[19] D. Hansell,et al. Effect of lung-volume-reduction surgery in patients with severe emphysema. , 2000, The New England journal of medicine.
[20] M. Niederman,et al. The role of bacteria in exacerbations of COPD. A constructive view. , 2000, Chest.
[21] J. Hirschmann. Do bacteria cause exacerbations of COPD? , 2000, Chest.
[22] R. Stockley,et al. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. , 2000, Chest.
[23] S. Spencer,et al. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial , 2000, BMJ : British Medical Journal.
[24] A. Anzueto,et al. Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD. , 2000, Chest.
[25] N. Pride,et al. Tumour necrosis factor-α gene promoter polymorphism in chronic obstructive pulmonary disease , 2000 .
[26] K. Chung,et al. No effect of inhaled budesonide on the response to inhaled ozone in normal subjects. , 2000, American journal of respiratory and critical care medicine.
[27] S. Ramsey,et al. The economic burden of COPD. , 2000, Chest.
[28] P. Barnes,et al. Mechanisms in COPD: differences from asthma. , 2000, Chest.
[29] T. Seemungal,et al. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations , 2000, Thorax.
[30] N. Payne,et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial , 2000, The Lancet.
[31] Dirkje S Postma,et al. Ongoing airway inflammation in patients with COPD who do not currently smoke , 1999, Chest.
[32] Joan Wilson,et al. Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.
[33] G. Criner,et al. Prospective Randomized Trial Comparing Bilateral Lung Volume Reduction Surgery to Pulmonary Rehabilitation in Severe Chronic Obstructive Pulmonary Disease , 1999 .
[34] D. Postma,et al. Asthma attacks with eosinophilia predict mortality from chronic obstructive pulmonary disease in a general population sample. , 1999, American journal of respiratory and critical care medicine.
[35] S. Sethi. Etiology and Management of Infections in Chronic Obstructive Pulmonary Disease , 1999 .
[36] A. Chaouat,et al. A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients. , 1999, The European respiratory journal.
[37] R. Stockley. Neutrophils and protease/antiprotease imbalance. , 1999, American journal of respiratory and critical care medicine.
[38] A. Torres,et al. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. , 1999, The European respiratory journal.
[39] W. Maziak,et al. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.
[40] P. Barnes,et al. Novel approaches and targets for treatment of chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.
[41] A. Agustí,et al. Serial measurements of exhaled nitric oxide during exacerbations of chronic obstructive pulmonary disease. , 1999, The European respiratory journal.
[42] N. Keicho,et al. Endotoxin-specific NF-κB activation in pulmonary epithelial cells harboring adenovirus E1A. , 1999, American journal of physiology. Lung cellular and molecular physiology.
[43] R. Stockley,et al. The interrelationship of sputum inflammatory markers in patients with chronic bronchitis. , 1999, American journal of respiratory and critical care medicine.
[44] T. Murphy,et al. Analysis of Antigenic Structure and Human Immune Response to Outer Membrane Protein CD of Moraxella catarrhalis , 1999, Infection and Immunity.
[45] L. Davies,et al. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial , 1999, The Lancet.
[46] D. Hornick,et al. Infection of Primary Human Bronchial Epithelial Cells by Haemophilus influenzae: Macropinocytosis as a Mechanism of Airway Epithelial Cell Entry , 1999, Infection and Immunity.
[47] B. Isalska,et al. Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection. , 1999, American journal of respiratory and critical care medicine.
[48] D. Postma,et al. Long-Term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue Smoking , 1999 .
[49] D. Niewoehner,et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. , 1999, The New England journal of medicine.
[50] S. Shapiro,et al. Matrix metalloproteinases. Matrix degradation and more. , 1999, American journal of respiratory cell and molecular biology.
[51] P. Lange,et al. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial , 1999, The Lancet.
[52] T. Braciale,et al. Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand. , 1999, American journal of respiratory cell and molecular biology.
[53] J. Dankert,et al. Haemophilus influenzae localized in epithelial cell layers is shielded from antibiotics and antibody-mediated bactericidal activity. , 1999, Microbial pathogenesis.
[54] C. Westermann,et al. Effects of formoterol in apparently poorly reversible chronic obstructive pulmonary disease. , 1999, The European respiratory journal.
[55] T. Seemungal,et al. Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease. , 1999, The European respiratory journal.
[56] S. Christensen,et al. Ariflo (SB 207499), a second generation phosphodiesterase 4 inhibitor for the treatment of asthma and COPD: from concept to clinic. , 1999, Pulmonary pharmacology & therapeutics.
[57] J. Nadel,et al. Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum. , 1999, American journal of respiratory cell and molecular biology.
[58] S. Yancey,et al. Efficacy of salmeterol xinafoate in the treatment of COPD. , 1999, Chest.
[59] F. Maltais,et al. Altered expression of myosin heavy chain in the vastus lateralis muscle in patients with COPD. , 1999, The European respiratory journal.
[60] Aker,et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. , 1999, The New England journal of medicine.
[61] P. Barnes. Molecular genetics of chronic obstructive pulmonary disease , 1999 .
[62] J. C. Campbell,et al. Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis. , 1999, The Journal of antimicrobial chemotherapy.
[63] T. Witek,et al. Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease. , 1999, Life sciences.
[64] Steven Piantadosi,et al. Rationale and design of the national emphysema treatment trial: A prospective randomized trial of lung volume reduction surgery , 1999 .
[65] T. Betsuyaku,et al. Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema. , 1999, American journal of respiratory and critical care medicine.
[66] E. Wouters,et al. Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.
[67] R. Richmond. Teaching medical students about tobacco. , 1999, Thorax.
[68] F. Brennan,et al. Anti-TNF alpha therapy is useful in rheumatoid arthritis and Crohn's disease: analysis of the mechanism of action predicts utility in other diseases. , 1998, Transplantation proceedings.
[69] G. FitzGerald,et al. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress. , 1998, American journal of respiratory and critical care medicine.
[70] D. O’Donnell,et al. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[71] X. Busquets,et al. Expression of adhesion molecules and G proteins in circulating neutrophils in chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[72] A. Anzueto,et al. Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[73] L. Fabbri,et al. Severity of airflow limitation is associated with severity of airway inflammation in smokers. , 1998, American journal of respiratory and critical care medicine.
[74] M J Connolly,et al. Quality of life in elderly patients with COPD: measurement and predictive factors. , 1998, Respiratory medicine.
[75] Y. Konttinen,et al. Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[76] M. Antonelli,et al. A Comparison of Noninvasive Positive-Pressure Ventilation and Conventional Mechanical Ventilation in Patients with Acute Respiratory Failure , 1998 .
[77] D. Felmingham. REVIEW OF THE COMPARATIVE IN VITRO ACTIVITY OF SOME ORAL CEPHALOSPORINS , 1998 .
[78] D. Nicolau. PHARMACODYNAMIC CONSIDERATIONS IN ORAL CEPHALOSPORIN THERAPY-. IMPLICATIONS FOR SELECTION AND EFFECTIVENESS , 1998 .
[79] F. Maltais,et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[80] B. Balbi,et al. Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. , 1998, The European respiratory journal.
[81] C. Sanguinetti,et al. Airways microbial flora in COPD patients in stable clinical conditions and during exacerbations: a bronchoscopic investigation. , 1998, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.
[82] B Rosner,et al. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. , 1998, American journal of respiratory and critical care medicine.
[83] M. Niederman,et al. Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. , 1998, Chest.
[84] D. Lomas,et al. Alpha1-antitrypsin deficiency, cirrhosis and emphysema , 1998 .
[85] S. E. Jones,et al. Domiciliary nocturnal intermittent positive pressure ventilation in patients with respiratory failure due to severe COPD: long term follow up and effect on survival , 1998, Thorax.
[86] R. Rodríguez-Roisín,et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. , 1998, American journal of respiratory and critical care medicine.
[87] T. Seemungal,et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[88] R. Hertzberg,et al. Identification of a Potent, Selective Non-peptide CXCR2 Antagonist That Inhibits Interleukin-8-induced Neutrophil Migration* , 1998, The Journal of Biological Chemistry.
[89] David W. Kaczka,et al. Relation between preoperative inspiratory lung resistance and the outcome of lung-volume-reduction surgery for emphysema. , 1998, The New England journal of medicine.
[90] P. Paggiaro,et al. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease , 1998, The Lancet.
[91] L. Fabbri,et al. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[92] W. Timens,et al. Haemophilus influenzae in lung explants of patients with end-stage pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[93] W. Maziak,et al. Exhaled nitric oxide in chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[94] P. Jeffery,et al. Structural and inflammatory changes in COPD: a comparison with asthma. , 1998, Thorax.
[95] T. Torphy. Phosphodiesterase isozymes: molecular targets for novel antiasthma agents. , 1998, American journal of respiratory and critical care medicine.
[96] P. Barnes. New therapies for chronic obstructive pulmonary disease. , 1998, Thorax.
[97] E. Wouters,et al. Weight Loss Is a Reversible Factor in the Prognosis of Chronic Obstructive Pulmonary Disease , 1998 .
[98] R. Doyle,et al. Lung volume reduction surgery for the treatment of chronic obstructive pulmonary disease. , 1998, Advances in internal medicine.
[99] M. Johnson,et al. Effect of salmeterol on Haemophilus influenzae infection of respiratory mucosa in vitro. , 1998, The European respiratory journal.
[100] Alan D. Lopez,et al. The global burden of disease, 1990–2020 , 1998, Nature Medicine.
[101] E. R. Mcfadden,et al. Patterns of hospitalization in elderly patients with asthma and chronic obstructive pulmonary disease. , 1997, American journal of respiratory and critical care medicine.
[102] C Brennen,et al. Multiply Antibiotic Resistant Gram-Negative Bacilli in a Long Term Care Facility A Case Control Study of Patient rick Factors and Prior Antibiotic Use , 1997, Infection Control & Hospital Epidemiology.
[103] R. Grossman. Guidelines for the treatment of acute exacerbations of chronic bronchitis. , 1997, Chest.
[104] Song-Lih Huang,et al. Tumor Necrosis Factor- α Gene Polymorphism in Chronic Bronchitis , 1997 .
[105] D. Albanes,et al. The effect of alpha-tocopherol and beta-carotene supplementation on COPD symptoms. , 1997, American journal of respiratory and critical care medicine.
[106] T. Murphy,et al. Human immune response to nontypeable Haemophilus influenzae in chronic bronchitis. , 1997, The Journal of infectious diseases.
[107] S. Shapiro,et al. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. , 1997, Science.
[108] D. Harrison,et al. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema , 1997, The Lancet.
[109] A Bast,et al. Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. , 1997, American journal of respiratory and critical care medicine.
[110] D. Górecka,et al. Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. , 1997, Thorax.
[111] T. Murphy,et al. Antigenic characterization and analysis of the human immune response to outer membrane protein E of Branhamella catarrhalis , 1997, Infection and immunity.
[112] L. O’Driscoll,et al. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. , 1997, American journal of respiratory and critical care medicine.
[113] T. Kohyama,et al. Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells. , 1997, American journal of respiratory and critical care medicine.
[114] M. Karin,et al. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.
[115] A. Morice,et al. An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD) , 1997, The European respiratory journal.
[116] M. Leinonen,et al. Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease , 1997, Epidemiology and Infection.
[117] P. Jeffery,et al. Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. , 1997, American journal of respiratory and critical care medicine.
[118] P. Barnes,et al. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. , 1997, American journal of respiratory and critical care medicine.
[119] P. Borm,et al. Blood antioxidant status in coal dust induced respiratory disorders: a longitudinal evaluation of multiple biomarkers , 1997 .
[120] H Vannucchi,et al. Assessment of vitamin A status in chronic obstructive pulmonary disease patients and healthy smokers. , 1996, The American journal of clinical nutrition.
[121] G. Patterson,et al. Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. , 1996, The Journal of thoracic and cardiovascular surgery.
[122] G. O'Connor,et al. Urinary desmosine excretion in smokers with and without rapid decline of lung function: the Normative Aging Study. , 1996, American journal of respiratory and critical care medicine.
[123] Gordon H Guyatt,et al. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease , 1996, The Lancet.
[124] M. Reed. Clinical pharmacokinetics of amoxicillin and clavulanate. , 1996, The Pediatric infectious disease journal.
[125] W. MacNee,et al. Systemic oxidative stress in asthma, COPD, and smokers. , 1996, American journal of respiratory and critical care medicine.
[126] K. Aben,et al. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.
[127] E. Wouters,et al. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. , 1996, Thorax.
[128] S. Rennard,et al. Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials. , 1996, Chest.
[129] U. Kucich,et al. MR889, a neutrophil elastase inhibitor, in patients with chronic obstructive pulmonary disease: a double-blind, randomized, placebo-controlled clinical trial. , 1996, The European respiratory journal.
[130] A. Agustí,et al. Noninvasive ventilatory support does not facilitate recovery from acute respiratory failure in chronic obstructive pulmonary disease. , 1996, The European respiratory journal.
[131] J. M. Cousin,et al. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. , 1996, Journal of immunology.
[132] J. Vestbo,et al. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. , 1996, American journal of respiratory and critical care medicine.
[133] D. Maldonado,et al. Woodsmoke exposure and risk for obstructive airways disease among women. , 1996, Chest.
[134] R. Rogers,et al. Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients. , 1996, American journal of respiratory and critical care medicine.
[135] P. Barnes,et al. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. , 1996, American journal of respiratory and critical care medicine.
[136] T. Cawston. Metalloproteinase inhibitors and the prevention of connective tissue breakdown. , 1996, Pharmacology & therapeutics.
[137] J. Connett,et al. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. , 1996, American journal of respiratory and critical care medicine.
[138] W. Knaus,et al. Hospital and 1-Year Survival of Patients Admitted to Intensive Care Units With Acute Exacerbation of Chronic Obstructive Pulmonary Disease , 1995 .
[139] T. Betsuyaku,et al. Excessive neutrophil elastase in bronchoalveolar lavage fluid in subclinical emphysema. , 1995, American journal of respiratory and critical care medicine.
[140] M. Cosio,et al. Alveolar inflammation and its relation to emphysema in smokers. , 1995, American journal of respiratory and critical care medicine.
[141] L. Fabbri,et al. Effect of smoking cessation on airway inflammation in chronic bronchitis. , 1995, American journal of respiratory and critical care medicine.
[142] J. Ruiz,et al. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. , 1995, American journal of respiratory and critical care medicine.
[143] E. Wouters,et al. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. , 1995, American journal of respiratory and critical care medicine.
[144] B. Celli,et al. Long-term oxygen therapy. , 1995, The New England journal of medicine.
[145] R. Davies,et al. Effect of erythromycin on Haemophilus influenzae endotoxin-induced release of IL-6, IL-8 and sICAM-1 by cultured human bronchial epithelial cells. , 1995, The European respiratory journal.
[146] P. Jones,et al. Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD. , 1995, American journal of respiratory and critical care medicine.
[147] B. Meyboom-de Jong,et al. Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice. , 1995, Thorax.
[148] E. Shahar,et al. Fish consumption may limit the damage of smoking on the lung. , 1995, American journal of respiratory and critical care medicine.
[149] E. Vittinghoff,et al. Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis. , 1995, JAMA.
[150] J. M. Harris,et al. Acute infective exacerbations of chronic bronchitis. , 1995, QJM : monthly journal of the Association of Physicians.
[151] L. Fabbri,et al. Airway eosinophilia in chronic bronchitis during exacerbations. , 1994, American journal of respiratory and critical care medicine.
[152] R. Davies,et al. Effect of Haemophilus influenzae endotoxin on the synthesis of IL-6, IL-8, TNF-alpha and expression of ICAM-1 in cultured human bronchial epithelial cells. , 1994, The European respiratory journal.
[153] J. Mege,et al. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. , 1994, American journal of respiratory and critical care medicine.
[154] D. Strachan,et al. Chest illness in infancy and chronic respiratory disease in later life: an analysis by month of birth. , 1994, International journal of epidemiology.
[155] P. Laippala,et al. Prevalence of chronic obstructive pulmonary disease in elderly Finns. , 1994, Respiratory medicine.
[156] A. Askari. Nutrition and Diagnosis-Related Care, 3rd edition , 1994 .
[157] A. Lindberg,et al. Haemophilus influenzae resides and multiplies intracellularly in human adenoid tissue as demonstrated by in situ hybridization and bacterial viability assay , 1994, Infection and immunity.
[158] D. Mant,et al. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation , 1994, The Lancet.
[159] F. Blasi,et al. Chlamydia pneumoniae infection in acute exacerbations of COPD. , 1993, The European respiratory journal.
[160] T. Murphy,et al. Bacterial infection in chronic obstructive pulmonary disease. , 1992, The American review of respiratory disease.
[161] W. Jefferies,et al. Latent adenoviral infection in the pathogenesis of chronic airways obstruction. , 1992, The American review of respiratory disease.
[162] R. Millman,et al. Nocturnal positive-pressure ventilation via nasal mask in patients with severe chronic obstructive pulmonary disease. , 1991, The American review of respiratory disease.
[163] P. Allhoff,et al. The Second National Health and Nutrition Examination Survey (NHANES II) , 1991 .
[164] J. Fagon,et al. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients. , 1990, The American review of respiratory disease.
[165] George,et al. Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells. , 1990, The Journal of clinical investigation.
[166] N. Anthonisen,et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. , 1987, Annals of internal medicine.
[167] D. Musher,et al. Development of bactericidal antibody during Branhamella catarrhalis infection. , 1985, The Journal of infectious diseases.
[168] D. Musher,et al. Pneumonia and acute febrile tracheobronchitis due to haemophilus influenzae. , 1983, Annals of internal medicine.
[169] F. Speizer,et al. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. , 1983, The American review of respiratory disease.
[170] I. Gregg,et al. A study of infective and other factors in exacerbations of chronic bronchitis , 1980, British Journal of Diseases of the Chest.
[171] R. Kanner,et al. Interactions between Viruses and Bacteria in Patients with Chronic Bronchitis , 1976, The Journal of infectious diseases.
[172] C. A. Phillips,et al. Role of infection in chronic bronchitis. , 1976, The American review of respiratory disease.
[173] F. Speizer,et al. Role of infection in chronic bronchitis. , 1975, The New England journal of medicine.
[174] B. Burrows,et al. Course and prognosis of chronic obstructive lung disease. A prospective study of 200 patients. , 1969, The New England journal of medicine.
[175] Fletcher Cm. Chronic bronchitis. Its prevalence, nature, and pathogenesis. , 1959 .